Jun Wang - Yubo International Pres CEO

All Insiders . USA . 
Stock . Yubo International Biotech . Stakeholders . Insider . Jun Wang
YBGJ Stock  USD 0.07  0.0001  0.15%   

Insider

Jun Wang is Pres CEO of Yubo International Biotech
Age 55
Phone86 10 6615 5141
Webhttps://www.yubogroup.com

Yubo International Management Efficiency

The company has return on total asset (ROA) of (0.2626) % which means that it has lost $0.2626 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (20.2251) %, meaning that it created substantial loss on money invested by shareholders. Yubo International's management efficiency ratios could be used to measure how well Yubo International manages its routine affairs as well as how well it operates its assets and liabilities.
Yubo International Biotech currently holds 2.4 M in liabilities. Yubo International has a current ratio of 0.25, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Yubo International until it has trouble settling it off, either with new capital or with free cash flow. So, Yubo International's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Yubo International sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Yubo to invest in growth at high rates of return. When we think about Yubo International's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Soheil ShamsBionano Genomics
60
Steven MDSharps Technology
63
Mark OldakowskiBionano Genomics
51
Esq CPAGlucoTrack
59
DSc ODPredictive Oncology
N/A
Julia KirshnerPredictive Oncology
N/A
David BAGlucoTrack
60
Donna PolizioBionano Genomics
N/A
Alan BlackmanSharps Technology
75
Mark CPABionano Genomics
N/A
MS MBABionano Genomics
N/A
Christopher StewartBionano Genomics
54
Alka FACMGBionano Genomics
52
Andrew CPASharps Technology
69
Robert HayesSharps Technology
57
Robert MBAPredictive Oncology
69
MScEE MBAGlucoTrack
71
Jonathan DixonBionano Genomics
N/A
Robert MyersPredictive Oncology
67
Erez BenZviGlucoTrack
46
Raymond VennarePredictive Oncology
73
Yubo International Biotech Limited, thorough its subsidiaries, focuses on the research and development, and application of endometrial stem cells. It offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. Yubo Intl is traded on OTC Exchange in the United States. Yubo International Biotech [YBGJ] is a Pink Sheet which is traded between independent brokers as part of over-the-counter (OTC) trading.

Management Performance

Return On Equity-20.23
Return On Asset-0.26

Yubo International Leadership Team

Elected by the shareholders, the Yubo International's board of directors comprises two types of representatives: Yubo International inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Yubo. The board's role is to monitor Yubo International's management team and ensure that shareholders' interests are well served. Yubo International's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Yubo International's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jun Wang, Pres CEO
Lina Liu, Treasurer CFO

Yubo Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Yubo International a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-20.23
Return On Asset-0.26
Operating Margin(4.59) %
Current Valuation14.08 M
Shares Outstanding119.82 M
Shares Owned By Insiders95.45 %
Price To Book61.23 X
Price To Sales26.55 X
Revenue1.24 B
Gross Profit820.65 K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in Yubo Pink Sheet

Yubo International financial ratios help investors to determine whether Yubo Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Yubo with respect to the benefits of owning Yubo International security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY